Novo Nordisk's Wegovy Weight-Loss Pill Shows Promising Early Sales Data

Novo Nordisk's new Wegovy weight-loss pill records over 3,000 prescriptions in its first four days, signaling strong market entry as competition with Eli Lilly intensifies in the booming obesity treatment sector.